April 13, 2020
The clinical research industry has been rapidly remodeled by the digital revolution.
This paradigm shift is exploding into a new way of drug development and clinical trials. A way where patient experience is at utmost precedence.
Revolving business models, services, and products around the patient is becoming the new normal.
As the spread of COVID-19 has affected every industry, pharmaceutical and biotech companies are feeling the heat of it. In our last piece, we covered some of the issues the clinical trial industry, as a whole, was facing. With unexpected delays, over-flooded inboxes, and patient safety at risk, here are specific ways sponsors can and are alleviating the negative impact of the virus…
©2020 Cloudbyz Inc. All Rights Reserved.